GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Conformis Inc (NAS:CFMS) » Definitions » Forward Rate of Return (Yacktman) %

Conformis (Conformis) Forward Rate of Return (Yacktman) % : 0.00% (As of Jun. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Conformis Forward Rate of Return (Yacktman) %?

Yacktman defines forward rate of return as the normalized free cash flow yield plus real growth plus inflation. Conformis's forward rate of return for was 0.00%.

The historical rank and industry rank for Conformis's Forward Rate of Return (Yacktman) % or its related term are showing as below:

During the past 10 years, Conformis's highest Forward Rate of Return was 20.00. The lowest was 20.00. And the median was 20.00.

CFMS's Forward Rate of Return (Yacktman) % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 11.62
* Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.

Unlike the Earnings Yield %, the Forward Rate of Return uses the normalized Free Cash Flow of the past seven years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.


Conformis Forward Rate of Return (Yacktman) % Historical Data

The historical data trend for Conformis's Forward Rate of Return (Yacktman) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Conformis Forward Rate of Return (Yacktman) % Chart

Conformis Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Forward Rate of Return (Yacktman) %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Conformis Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Forward Rate of Return (Yacktman) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Conformis's Forward Rate of Return (Yacktman) %

For the Medical Devices subindustry, Conformis's Forward Rate of Return (Yacktman) %, along with its competitors' market caps and Forward Rate of Return (Yacktman) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Conformis's Forward Rate of Return (Yacktman) % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Conformis's Forward Rate of Return (Yacktman) % distribution charts can be found below:

* The bar in red indicates where Conformis's Forward Rate of Return (Yacktman) % falls into.



Conformis Forward Rate of Return (Yacktman) % Calculation

Forward Rate of Return is a concept that Don Yacktman uses in his investment approach. Yacktman explained the forward rate of return concept in detail in his interview with GuruFocus. Yacktman defines forward rate of return as the normalized free cash flow yield plus real growth plus inflation. He said in the interview (March 2012, when the S&P 500 was at about 1400):

If the business is stable, this calculation is fairly straightforward. For instance, on the S&P 500 we would normalize earnings. We would then calculate what percentage of those earnings are not reinvested in the underlying businesses and are therefore free. Historically, for the S&P 500, this has been just under 50% of earnings. Currently, we expect the S&P to earn about 70 on a normalized basis, a number which is far below reported earnings due to our adjusting for record high profit margins. $70 X ½ / 1400 gives you a normalized free cash flow yield of approximately 2.5%.

The historical real growth rate of the S&P 500 (companies) is about 1.5%. Assuming an inflation rate of 2.5%, the forward rate of return on an investment in the S&P 500 is about 6.5% today (2.5% free cash flow yield plus 1.5% real growth plus 2.5% inflation).

Conformis's Forward Rate of Return of Jun. 2023 is

Forward Rate of Return=Normalized Free Cash Flow/Price+5-Year EBITDA Growth Rate
=0/2.19+0
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Conformis  (NAS:CFMS) Forward Rate of Return (Yacktman) % Explanation

Unlike the Earnings Yield, the Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.

For the growth part of the Forward Rate of Return calculation, GuruFocus uses the 5-year average growth rate of EBITDA per share as the growth rate, and the growth rate is always capped at 20%. For the Free Cash Flow we use per share data averaged over five years. The reason we use five years is to make it comparable to the growth rate.


Be Aware

In the Forward Rate of Return calculation, the growth rate is added directly to today's free cash flow yield. Therefore the calculation is reliable only if the company can grow at the same rate in the future as it did in the past. Investors should pay close attention to this when researching growth stocks. A more accurate measurement for return is Return on Capital.


Conformis Forward Rate of Return (Yacktman) % Related Terms

Thank you for viewing the detailed overview of Conformis's Forward Rate of Return (Yacktman) % provided by GuruFocus.com. Please click on the following links to see related term pages.


Conformis (Conformis) Business Description

Traded in Other Exchanges
N/A
Address
600 Technology Park Drive, Billerica, MA, USA, 01821
Conformis Inc is a United States-based medical technology company. It uses the iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are individually sized and shaped to fit each patient's anatomy. The company's iFit technology platform comprises three key elements which are iFit design, iFit printing, and iFit just-in-time delivery. It offers various partial and total knee replacement implants which include iTotal CR, iTotal PS, iDuo, and iUni. The company operates in the segment of the knee replacement market. Its total revenue is generated from the sale of its products to hospitals and other medical facilities. The majority of the company's revenue comes from the United States.
Executives
Christine Desrochers officer: Fmr Interim CFO & Controller 600 TECHNOLOGY PARK DRIVE, 4TH FLOOR, BILLERICA MA 01821
Gary P Fischetti director 600 TECHNOLOGY PARK DRIVE, 4TH FLOOR, BILLERICA MA 01821
Mark A Augusti director, officer: FORMER PRESIDENT & CEO 40 WEST HIGHLAND PARK DRIVE NE, HUTCHINSON MN 55350
Denise E Pedulla officer: FORMER CLO & SECRETARY 12701 COMMONWEALTH DRIVE, SUITE 9, FORT MYERS FL 33913
Philip W Johnston director C/O CONFORMIS INC, 600, BILLERICA MA 01821
Carrie Bienkowski director C/O CONFORMIS INC, 600 TECHNOLOGY PARK DRIVE, BILLERICA MA 01821
Robert S Howe officer: CFO & TREASURER C/O CONFORMIS INC, 600 TECHNOLOGY PARK DRIVE, BILLERICA MA 01821
J Brent Alldredge officer: CLO & SECRETARY C/O CONFORMIS INC, 600 TECHNOLOGY PARK DRIVE, BILLERICA MA 01821
Fallon Kenneth P Iii director 5473 FOX HOLLOW DRIVE, NAPLES FL 34101
Erin Henry officer: CORP CONTROLLER & INTERIM PAO C/O CONFORMIS INC, 600 TECHNOLOGY PARK DRIVE, BILLERICA MA 01821
Frederick W Driscoll officer: INTERIM CFO & INTERIM TREAS
Paul S Weiner officer: Chief Financial Officer C/O CONFORMIS INC, 28 CROSBY DRIVE, BEDFORD MA 01730
Archon Capital Management Llc 10 percent owner 1100 19TH AVENUE EAST, SEATTLE WA 98112
Patricia A Davis officer: CLO & GENERAL COUNSEL C/O CONFORMIS INC, 600 TECHNOLOGY PARK DRIVE, BILLERICA MA 02181
Bradley Langdale director C/O CONFORMIS, INC., 28 CROSBY DRIVE, BEDFORD MA 01730